Meeting report: Pre-exposure human immunodeficiency virus prophylaxis in the EU/EEA: Challenges and opportunities, Stockholm April 2016

Eurosurveillance

Volumn 21, Issue 25, 2016, Pages

  Noori, Teymur ^a   Pharris, A ^a  

^a EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; GENERIC DRUG;

COST EFFECTIVENESS ANALYSIS; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MENTAL HEALTH; NOTE; PRE-EXPOSURE PROPHYLAXIS; SCREENING; SENSITIVITY ANALYSIS; SEROCONVERSION; SEXUALLY TRANSMITTED DISEASE; SOCIAL ASPECT; SYSTEMATIC REVIEW (TOPIC); EPIDEMIOLOGY; EUROPE; FEMALE; HEALTH PROMOTION; HIV INFECTIONS; MALE; PREVALENCE; PREVENTIVE HEALTH SERVICE; PROCEDURES; RISK FACTOR; VULNERABLE POPULATION;

EUROPE; FEMALE; HEALTH PROMOTION; HIV INFECTIONS; HUMANS; IMMUNIZATION PROGRAMS; MALE; PRE-EXPOSURE PROPHYLAXIS; PREVALENCE; RISK FACTORS; VULNERABLE POPULATIONS;

EID: 85015353068     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES.2016.21.25.30263     Document Type: Note

References (10)

1. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al., iPrEx Study Team. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27): 2587-99. DOI: 10.1056/NEJMoa1011205 PMID: 21091279
2. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al., Partners PrEP Study Team. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5): 399-410. DOI: 10.1056/NEJMoa1108524 PMID: 22784037
3. McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2016;387(10013): 53-60. DOI: 10.1016/S0140-6736(15)00056-2 PMID: 26364263
4. Molina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, et al., ANRS IPERGAY Study Group. On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection. N Engl J Med. 2015;373(23): 2237-46. DOI: 10.1056/NEJMoa1506273 PMID: 26624850
5. World Health Organization (WHO). Guideline on When to Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV. Geneva: WHO; 2015.
6. European Centre for Disease Prevention and Control (ECDC), WHO Regional Office for Europe (WHO). HIV/AIDS Surveillance in Europe 2014. Stockholm: ECDC/WHO; 2015.
7. European Centre for Disease Prevention and Control (ECDC). Sexually transmitted infections in Europe 2013. Stockholm: ECDC; 2013.
8. European Centre for Disease Prevention and Control (ECDC). HIV and STI prevention among men who have sex with men. Stockholm: ECDC; 2015.
9. United States Centers for Disease Control and Prevention (CDC). Pre-exposure prophylaxis for the prevention of HIV infection in the United States, 2014. Atlanta: CDC; 2014.
10. European AIDS Clinical Society (EACS). EACS Guidelines, Version 8.0. Brussels: EACS, 2015.